Editor-Opioids are common in early stages of labour as they are highly effective for visceral and somatic pain. The main concern of opioids in labour analgesia is the neonate exposure. 1 We have evaluated the early neurological outcome of the new-born infants of 15 healthy parturient, aged 21-40 yr, who were given intranasal fentanyl 100-250 µg (Instanyl ® nasal spray 50 µg dose Oy Leiras Takeda Pharmaceuticals Ab, Helsinki, Finland) when contraction pain was >5/10 (numerical rating scale (NRS) 0=no pain, 10=most pain). In a control group we enrolled 34 neonates born to mothers, aged 20-44 yr, who were provided labour analgesia without parenteral opioids. The study was approved by the local ethics committee, the Finnish Medicines Agency was notified, and it was recorded in the European Clinical Trials Database (EudraCT no. 2010-020501-32). Each parturient gave written informed consent. The fetal heart rate (FHR) during labour was monitored and continuously recorded by cardiotocography. Paired blood samples were obtained just after birth from mothers, and umbilical artery and vein samples when the umbilical cord was clamped and cut to analyse fentanyl concentrations. The blood samples were analysed with an ultra-performance liquid chromatographic system. 2 Neonatal outcome was assessed using Apgar scores, and drug effects using the Neurologic and Adaptive Capacity Score (NACS) 3 at 30-120 min after the birth. Amplitude integrated electroencephalography (aEEG) (Brainz BRM3 ® brain monitor, Natus Pediatrics, San Carlos, CA, USA) was recorded at 60-180 min after birth and at 24 h after the birth for the newborns to detect potential drug effects. 4 Standard EEG (Comet, Grass Technologies, Astro-Med, West Warwick, RI, USA) was recorded at 24 or 48 h after the birth. Any adverse outcomes of the neonate were recorded. Fentanyl was detected in seven out of 15 neonates' umbilical blood samples. The highest observed umbilical venous and arterial concentrations were 0.17 ng ml −1 and 0.11 ng ml −1 , respectively, and fetal to maternal fentanyl plasma concentration ratios ranged between 0.19 and 0.55, indicating low fetal exposure to fentanyl (Table 1 ). In the fentanyl group, aEEG was recorded in 10 infants both within two h and at 24 h after birth and one had a single recording. In the control group, two aEEG recordings were performed in 27 infants; and six infants had a single aEEG recording. In general the quality of recordings was good. All infants in both groups showed a normal continuous normal voltage background pattern. The original EEG of the aEEG showed neither epileptiform activity nor interhemispheric asymmetry. In the fentanyl group, standard EEG was recorded in eight infants and in 10 infants in the control group. In three infants, one in the fentanyl group and two in the control group, mild EEG abnormalities were identified. In one infant from the fentanyl group, the EEG showed a slightly immature background pattern with some short runs of bilateral central sharp transients. In the control group, one infant had mild interhemispheric asymmetry during quiet sleep, with pronounced delta waves and some sharp transients on the right hemisphere. Another control infant had some short runs of temporal sharp transients or beta activity without clinical symptoms. Major abnormalities were not found. In conclusion, no fetal adverse effects were observed after maternal intranasal fentanyl dosing, fentanyl concentrations at birth for full-term new-borns were low or below the detection limit. In this pilot study modest intranasal fentanyl dose of 250 µg or less appeared to be safe for new-born infants. However, a larger study is warranted to ensure maternal and fetal safety.
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